Get the Stockscreener App
2.8906
4.60%
-0.1394
Acasti Pharma Inc Stock (ACST) Forecast
The Acasti Pharma Inc (ACST) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.9746, representing a +72.10% increase from the current price of $2.8906. The highest analyst price target is $6.7048, and the lowest is $3.2444.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ACST Price Target
Average 10.66
(+268.75% Upside)
Is Acasti Pharma Inc (ACST) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.07 | Neutral |
| STOCH(9,6) | 38.35 | Neutral |
| STOCHRSI(14) | 85.58 | Sell |
| MACD(12,26) | -0.1117 | Sell |
| ADX(14) | 24.18 | Neutral |
| William %R | -53.62 | Neutral |
| CCI(14) | 18.25 | Neutral |
Buy: 0
Sell: 2
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.8792
Buy
|
2.9429
Buy
|
| MA20 |
3.0818
Sell
|
3.0355
Sell
|
| MA50 |
3.2716
Sell
|
3.0912
Sell
|
| MA100 |
2.9131
Buy
|
2.9257
Buy
|
| MA200 |
2.6137
Buy
|
2.4602
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, ACST could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on ACST, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 45.07 indicates that ACST is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 38.35 indicates that ACST is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 85.58 indicates that ACST is oversold. This suggests that ACST price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.18 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 18.25 indicates that ACST is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ACST price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Acasti Pharma Inc financial reports and earnings history, Acasti Pharma Inc (ACST) stock could reach $0.8089 by 2030, $5.5955 by 2040 and $11.23 by 2050. See the projected annual prices until 2050 of the Acasti Pharma Inc stock below:
- Acasti Pharma Inc (ACST) is expected to reach an average price of $1.4401 in 2035, with a high prediction of $1.4048 and a low estimate of $1.2754. This indicates an $-50.18% rise from the last recorded price of $2.8906.
- Acasti Pharma Inc (ACST) stock is projected to chart a bullish course in 2040, with an average price target of $5.5704, representing an $92.71% surge from its current level. The forecast ranges from a conservative $5.5794 to a sky-high $5.5955.
- Our analysts predict Acasti Pharma Inc (ACST) to jump 189.15% by 2045, soaring from $8.2698 to an average price of $8.3583, potentially reaching $8.3368. While $8.2698 is the low estimate, the potential upside is significant.
- Acasti Pharma Inc (ACST) stock is expected to climb by 2050, reaching an average of $11.16, a $286.09% jump from its current level. However, a wide range of estimates exists, with high and low targets of $11.23 and $11.29, respectively, highlighting the market's uncertainty.
Acasti Pharma Inc Stock (ACST) Year by Year Forecast
Acasti Pharma Inc Stock (ACST) Price Forecast for 2024
Our forecast for ACST stock price in 2024 now indicates an average price target of $11.04 with a high forecast of $20.10 and a low forecast of $1.98. The average prediction reflects an increase of +281.91% from the last recorded price of $2.8906.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $5.5832 | $3.2444 | $6.7048 | +93.15% |
| July, 2024 | $15.58 | $5.4316 | $20.10 | +438.94% |
| August, 2024 | $11.17 | $10.61 | $17.47 | +286.28% |
| September, 2024 | $13.22 | $8.8527 | $14.95 | +357.44% |
| October, 2024 | $12.73 | $10.73 | $14.42 | +340.54% |
| November, 2024 | $12.05 | $10.85 | $13.73 | +317.01% |
| December, 2024 | $11.48 | $11.12 | $15.43 | +297.19% |
Acasti Pharma Inc Stock (ACST) Price Forecast for 2025
Acasti Pharma Inc Stock (ACST) is expected to reach an average price of $10.66 in 2025, with a high prediction of $21.30 and a low estimate of $0.0163. This indicates an +268.75% rise from the last recorded price of $2.8906.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $14.96 | $6.1416 | $21.30 | +417.37% |
| February, 2025 | $2.6464 | $0.8096 | $17.00 | -8.45% |
| March, 2025 | $0.1431 | $0.0705 | $3.6691 | -95.05% |
| April, 2025 | $0.2286 | $0.0163 | $0.6499 | -92.09% |
| May, 2025 | $1.4114 | $0.0882 | $2.5506 | -51.17% |
| June, 2025 | $1.7953 | $0.9974 | $2.4169 | -37.89% |
| July, 2025 | $2.7485 | $1.7045 | $4.5181 | -4.92% |
| August, 2025 | $2.546 | $0.3852 | $2.9385 | -11.92% |
| September, 2025 | $3.2084 | $1.6992 | $3.546 | +10.99% |
| October, 2025 | $1.4457 | $1.2221 | $3.5595 | -49.99% |
| November, 2025 | $1.4314 | $1.433 | $1.2933 | -50.48% |
| December, 2025 | $1.511 | $1.4126 | $1.3622 | -47.73% |
Acasti Pharma Inc Stock (ACST) Price Forecast for 2026
The predicted value for Acasti Pharma Inc (ACST) in 2026 is set at an average of $3.4848. Estimates vary from a peak of $6.8696 to a trough of $0.10, indicating an +20.56% surge from the present price of $2.8906.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.9503 | $1.2727 | $1.4338 | -67.13% |
| February, 2026 | $0.8815 | $0.6383 | $0.7447 | -69.50% |
| March, 2026 | $1.8792 | $0.3644 | $3.9464 | -34.99% |
| April, 2026 | $4.598 | $1.656 | $6.8696 | +59.07% |
| May, 2026 | $2.6075 | $0.9699 | $4.6015 | -9.79% |
| June, 2026 | $1.481 | $1.3306 | $3.1023 | -48.76% |
| July, 2026 | $0.6926 | $0.2254 | $2.1562 | -76.04% |
| August, 2026 | $1.6509 | $0.6138 | $2.1277 | -42.89% |
| September, 2026 | $1.6257 | $1.0853 | $2.6853 | -43.76% |
| October, 2026 | $1.0576 | $0.75 | $1.8325 | -63.41% |
| November, 2026 | $0.01 | $0.10 | $1.1916 | -99.65% |
| December, 2026 | $0.6561 | $0.3033 | $0.3029 | -77.30% |
Acasti Pharma Inc Stock (ACST) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Acasti Pharma Inc (ACST) is $1.0776, with a high forecast of $1.4659 and a low forecast of $0.6893. This indicates an -62.72% decrease from the last price of $2.8906.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.944 | $0.6893 | $0.8107 | -67.34% |
| February, 2027 | $1.1318 | $0.9454 | $0.9518 | -60.85% |
| March, 2027 | $1.4179 | $1.2982 | $1.3879 | -50.95% |
| April, 2027 | $1.1407 | $1.2875 | $1.1155 | -60.54% |
| May, 2027 | $1.3536 | $1.3539 | $1.3131 | -53.17% |
| June, 2027 | $1.4107 | $1.33 | $1.3265 | -51.20% |
| July, 2027 | $1.2225 | $1.2725 | $1.3677 | -57.71% |
| August, 2027 | $1.3153 | $1.2357 | $1.2007 | -54.50% |
| September, 2027 | $1.4348 | $1.3786 | $1.4129 | -50.36% |
| October, 2027 | $1.4243 | $1.4307 | $1.3846 | -50.73% |
| November, 2027 | $1.4297 | $1.4696 | $1.4659 | -50.54% |
| December, 2027 | $1.3382 | $1.4532 | $1.43 | -53.71% |
Acasti Pharma Inc Stock (ACST) Price Forecast for 2028
In 2028, Acasti Pharma Inc (ACST) is projected to reach an average price of $1.5767, with a high projection of $1.7544 and a low estimate of $1.399. This indicates an -45.45% fall from the last price of $2.8906.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.446 | $1.4054 | $1.4161 | -49.97% |
| February, 2028 | $1.6554 | $1.4818 | $1.6202 | -42.73% |
| March, 2028 | $1.639 | $1.6503 | $1.6317 | -43.30% |
| April, 2028 | $1.7579 | $1.6568 | $1.7288 | -39.19% |
| May, 2028 | $1.6198 | $1.7583 | $1.7544 | -43.96% |
| June, 2028 | $1.3037 | $1.4067 | $1.5751 | -54.90% |
| July, 2028 | $1.4106 | $1.4231 | $1.3864 | -51.20% |
| August, 2028 | $1.5956 | $1.4828 | $1.5364 | -44.80% |
| September, 2028 | $1.5893 | $1.6083 | $1.5763 | -45.02% |
| October, 2028 | $1.5535 | $1.5549 | $1.5363 | -46.26% |
| November, 2028 | $1.4302 | $1.4473 | $1.4996 | -50.52% |
| December, 2028 | $1.4152 | $1.399 | $1.3906 | -51.04% |
Acasti Pharma Inc Stock (ACST) Price Forecast for 2029
The 2029 price forecast for Acasti Pharma Inc Stock (ACST) is $0.9895 on average, with a high prediction of $1.9144 and a low estimate of $0.0647. This represents an -65.77% decrease from the previous price of $2.8906.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.6737 | $0.3233 | $1.8327 | -76.69% |
| February, 2029 | $0.1358 | $0.1208 | $0.6805 | -95.30% |
| March, 2029 | $0.158 | $0.0647 | $0.3911 | -94.54% |
| April, 2029 | $0.7751 | $0.0985 | $1.2731 | -73.18% |
| May, 2029 | $0.4328 | $0.3891 | $0.9282 | -85.03% |
| June, 2029 | $0.3962 | $0.2294 | $0.4658 | -86.29% |
| July, 2029 | $1.1533 | $0.2298 | $1.4433 | -60.10% |
| August, 2029 | $0.7773 | $0.2637 | $1.4169 | -73.11% |
| September, 2029 | $1.6744 | $0.5609 | $1.9144 | -42.07% |
| October, 2029 | $1.7584 | $1.56 | $1.8448 | -39.17% |
| November, 2029 | $1.2555 | $1.2555 | $1.8719 | -56.57% |
| December, 2029 | $0.7326 | $0.9222 | $1.5523 | -74.66% |
Acasti Pharma Inc Stock (ACST) Price Forecast for 2030
Acasti Pharma Inc Stock (ACST) is expected to reach an average price of $8.9997 in 2030, with a high forecast of $17.96 and a low forecast of $0.036. This signifies an +211.34% surge from the last price of $2.8906.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.0281 | $0.1367 | $0.8089 | -99.03% |
| February, 2030 | $4.4368 | $0.036 | $4.9568 | +53.49% |
| March, 2030 | $12.22 | $3.9303 | $16.60 | +322.72% |
| April, 2030 | $7.9454 | $5.3854 | $12.46 | +174.87% |
| May, 2030 | $8.0932 | $7.3189 | $11.49 | +179.98% |
| June, 2030 | $8.3075 | $7.3068 | $11.01 | +187.40% |
| July, 2030 | $9.4154 | $7.4523 | $12.06 | +225.72% |
| August, 2030 | $15.99 | $7.0561 | $16.83 | +453.16% |
| September, 2030 | $10.92 | $2.8033 | $17.96 | +277.91% |
| October, 2030 | $1.9881 | $0.8849 | $1.3776 | -31.22% |
| November, 2030 | $4.0163 | $2.3306 | $3.0027 | +38.94% |
| December, 2030 | $3.7996 | $3.6731 | $3.7811 | +31.45% |
1.36%
6.89%
Cap:
|
Volume (24h):